Half-year report · Q2
7446.TEDINET S100VQQA
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥17.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥32.2bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥325m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥276m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥355m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥408m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥302m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥400m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥314m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥269m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥237m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥211m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥273m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥213m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥18.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥17.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥19.8bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.8bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.7bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥764m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥745m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥674m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.0bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥226m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥62m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥108m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥54m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥210m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥83m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥298.4 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥263.54 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥233.86 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥17.8bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥17.8bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥8.3bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥8.3bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥7.1bn |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥16.6bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥16.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 508
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 80014000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -108013000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | － | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -24442000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -16414000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 34448000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | － | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -5000000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -8000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | 75000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 8000000 | JPY |
| Purchase of insurance funds inv cf | Prior1YTDDuration | － | JPY |
| Purchase of insurance funds inv cf | CurrentYTDDuration | -2330000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | 11083000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | － | JPY |
| Other net inv cf | Prior1YTDDuration | 5938000 | JPY |
| Other net inv cf | CurrentYTDDuration | 6345000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -53790000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 62144000 | JPY |
| Increase in short term loans payable fin cf | Prior1YTDDuration | 1895000000 | JPY |
| Increase in short term loans payable fin cf | CurrentYTDDuration | 2031000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1YTDDuration | -1846200000 | JPY |
| Decrease in short term loans payable fin cf | CurrentYTDDuration | -1888000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -7140000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -14340000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -94457000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -93959000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -30080000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -28216000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -82878000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 6484000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 89628000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 742818000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2106274000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 744586000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 2195902000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1487404000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 757049000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 735222000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 1635000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -1077000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 54410000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 57030000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 21093000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 17978000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 6005000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 5635000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02810-000IndustrySalesGroupReportableSegmentMember | 8335487000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02810-000MedicalSalesGroupReportableSegmentMember | 7104352000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |